Aminocaproic Acid

CHEMBL1046 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
131.2 g/mol
LogP
-3.0
Phase
4

An antifibrinolytic drug that inhibits plasminogen activators and plasmin, thereby preventing the breakdown of blood clots that have already formed at sites of bleeding. It is used to control excessive bleeding in conditions where the body's clot-dissolving system is overactive, including after surgery and dental procedures in hemophilia patients.

分子量

131.1700 g/mol

LogP

-3.00

TPSA

63.30 Ų

リピンスキーの五則

適合

治療領域

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

NCCCCCC(=O)O

InChI

InChI=1S/C6H13NO2/c7-5-3-1-2-4-6(8)9/h1-5,7H2,(H,8,9)

Molecular Formula

C6H13NO2

HBD / HBA

2 / 3

回転可能結合数

5

重原子数

9

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

An antifibrinolytic drug that inhibits plasminogen activators and plasmin, thereby preventing the breakdown of blood clots that have already formed at sites of bleeding. It is used to control excessive bleeding in conditions where the body's clot-dissolving system is overactive, including after surgery and dental procedures in hemophilia patients.

Yes, Aminocaproic Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1046. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 564. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.